麻豆传媒

Selected highlights from the 2024 American College of Gastroenterology annual meeting

Public health and access to care are at stake in the 2024 election

Also in TTHealthWatch: menopause hormone therapy in the U.S.

But further investigations capable are warranted to confirm the findings, researcher says

Researchers advocate away from over-medicalizing menopause

Late menarche, early menopause both seen as increasing risk

These patients may be undertreated with hormone therapy, expert suggested

Updated recommendation applies to oral or transdermal delivery

Risk with hormone replacement therapy lingers in the long run, though

Swedish study finds reduced DFS in women who used drugs for hot flashes

Prescribing rate is half that of women with no breast cancer history

Research suggests new tools for risk stratification and therapy

Biggest drivers were HIV, suicide, and heart problems

News and commentary from the endocrinology world